Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and anti-caries efficacy of COL 101 arginine non-fluoride dentifrice versus a 0.24% sodium fluoride dentifrice in 10- to 14-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 0.24% Sodium Fluoride Dentifrice (1100 ppm F) (Sodium fluoride dentifrice)
  • COL 101 Arginine Non-fluoride Dentifrice (Arginine-based non-fluoride dentifrice)

Snippet

Sponsor: Colgate Palmolive | Conditions: Dental Caries | Phase 2 | Status: COMPLETED